Dexamethasone palmitate-loaded nanodiscs target inflamed joints and suppress rheumatoid arthritis.
Rheumatoid arthritis (RA) is driven by persistent joint inflammation and dysregulated adaptive immune responses, highlighting the need for drug delivery strategies that can concentrate immunomodulatory therapy at inflamed joints and disease-associated lymphatic tissues. Here, we formulated dexamethasone palmitate-loade...